Australian Pharmaceutical Industries

Australian Pharmaceutical Industries (API) is an Australian health and beauty company whose activities have centred on pharmaceutical wholesaling, pharmacy retailing and the manufacture or distribution of healthcare products. The company is described as Australia’s largest wholesale distributor of pharmaceuticals and allied products, supplying community pharmacies and institutional healthcare customers while also operating retail and franchise businesses. The business began in 1910 as Chemists’ Co-operative of New South Wales Limited. It subsequently traded as Wholesale Drug Co before adopting the Australian Pharmaceutical Industries name in 1971. Its original cooperative and wholesale orientation remained important as the company expanded beyond traditional pharmacy distribution into medical, surgical, hospital and consumer-health categories. API grew through a series of acquisitions. In 1996 it bought Newmans & Western Pharmaceuticals, followed in 1997 by Amed Supplies Australia, which broadened its medical and surgical coverage for hospital customers. The company became publicly traded on the Australian Securities Exchange on 16 June 1997. It launched the Chemworld Chemist banner in 1998 and acquired the pharmaceutical wholesaling and manufacturing operations of Washington H. Soul Pattinson in 2000. The purchase of Hospital Supplies of Australia in 2001 extended its reach into public and private hospitals. The company also pursued expansion in New Zealand. In 2002 it acquired the Interpacific and Interpharma businesses, including operations associated with pharmacy wholesaling and retailing, over-the-counter pharmaceutical manufacturing and dental-product distribution. API later sold its New Zealand healthcare and logistics pharmacy business in 2005, reflecting a gradual concentration on its Australian pharmacy channel. Retail became a more prominent part of the strategy in the 2000s. In 2004 API acquired the Priceline, Priceline Pharmacy, House and Price Attack retail brands from New Price Retail. The transaction helped shift the company toward an integrated distribution-and-retail model, with Priceline Pharmacy becoming the principal focus. API sold Halas Dental in 2005 and divested House and Price Attack in 2007 as it narrowed its retail emphasis. API subsequently developed a broader health, beauty and pharmacy portfolio. It agreed in 2018 to acquire Clearskincare Clinics, initially taking a majority interest and moving to full ownership by September 2021. Wesfarmers acquired API for A$774 million in March 2022, ending its period as an independently listed company and placing the business within the Wesfarmers group. In November 2023 API acquired Silk Laser Clinics, adding another appearance- and aesthetic-treatment business to its portfolio. The company’s retail health and beauty activities have operated under brands including Soul Pattinson and Pharmacist Advice, while its history is closely associated with Priceline and Priceline Pharmacy. API’s role combines wholesale logistics, pharmacy support, retail and franchise operations, and selected health and beauty services rather than being limited to conventional pharmaceutical manufacturing. Following the Wesfarmers acquisition, API continues as an operating business within a larger Australian diversified group.

Australian Pharmaceutical Industries traces its origins to 1910, when it was incorporated as Chemists’ Co-operative of New South Wales Limited. The enterprise was established around the needs of pharmacy businesses and developed as a wholesale supplier of medicines and allied goods. It later operated under the name Wholesale Drug Co and adopted the Australian Pharmaceutical Industries name in 1971. The company expanded its wholesale base through acquisitions during the 1990s. Newmans & Western Pharmaceuticals was acquired in 1996, and Amed Supplies Australia followed in 1997. The latter transaction strengthened API’s position in medical and surgical supplies and increased its capacity to serve hospital customers. API was listed on the Australian Securities Exchange on 16 June 1997. Retail pharmacy became an increasingly important strategic direction. API introduced the Chemworld Chemist banner in 1998 and acquired the pharmaceutical wholesaling and manufacturing operations of Washington H. Soul Pattinson in 2000. On 29 October 2001, it purchased Hospital Supplies of Australia, previously owned by the Victorian Healthcare Association. This acquisition enabled API to distribute to public and private hospitals as well as community pharmacies. In 2002, API acquired Interpacific and Interpharma in New Zealand. The acquired activities included pharmacy wholesaling and retailing, over-the-counter pharmaceutical manufacturing and dental-product distribution, with businesses including Zuellig Pharma, PSM Healthcare and Halas Dental. API later sold its New Zealand healthcare and logistics pharmacy business on 14 December 2005. It also sold the Halas Dental business in 2005 as part of a more focused pharmacy strategy. A major retail development came on 6 October 2004, when API acquired Priceline, Priceline Pharmacy, House and Price Attack from New Price Retail. The transaction accelerated API’s move toward a retail-led model, particularly through Priceline Pharmacy. In 2005, the company formed a joint venture with ABN AMRO Capital Advisory Australia; the joint venture subsequently acquired Clifford Hallam Pharmaceuticals. In 2007 API divested House and Price Attack, concentrating its retail attention on Priceline. API experienced a significant accounting controversy in 2006. Following the introduction of a new IT system, the company discovered that A$17.2 million of previously declared profit could not be traced. Forensic accountants were unable to locate the missing amount, and API wrote the entire figure off in its annual results, resulting in a reported net loss of A$17.2 million. Chief executive Jeff Sher resigned after a disagreement with the board concerning the strategic handling of the discrepancy. The issue was later understood to have historical relevance predating API’s acquisition of Priceline. The company continued to broaden its health and beauty activities in the late 2010s and 2020s. In 2018 API agreed to acquire Clearskincare Clinics, initially purchasing a 50.1 percent interest and increasing its ownership to 100 percent by the end of September 2021. Wesfarmers acquired API for A$774 million in March 2022, ending API’s independent ASX-listed status. API then acquired Silk Laser Clinics in November 2023. API’s business has therefore evolved from a cooperative pharmaceutical wholesaler into an integrated Australian health and beauty platform. Its activities encompass wholesale distribution, pharmacy retailing, franchise support, consumer health and beauty, and clinic-based skin-care and aesthetic services. Its retail presence has included the Soul Pattinson and Pharmacist Advice brands, while Priceline and Priceline Pharmacy have been central to its modern retail history.

• 2023

  Acquisition of Silk Laser Clinics

  [1]Australian Pharmaceutical Industriesen.wikipedia.org

  API added Silk Laser Clinics to its health and beauty portfolio.

• 2022

  Acquired by Wesfarmers

  [1]Australian Pharmaceutical Industriesen.wikipedia.org

  Wesfarmers acquired API for A$774 million, ending its independent listed-company status.

• 2021

  Reaches full ownership of Clearskincare Clinics

  [1]Australian Pharmaceutical Industriesen.wikipedia.org

  API increased its ownership of Clearskincare Clinics to 100 percent by the end of September.

• 2018

  Agreement to acquire Clearskincare Clinics

  [1]Australian Pharmaceutical Industriesen.wikipedia.org

  API agreed to acquire a majority stake in the skin-care clinic business, later moving to full ownership.

• 2007

  Divestment of House and Price Attack

  [1]Australian Pharmaceutical Industriesen.wikipedia.org

  API sold the two retail brands to concentrate its strategy on Priceline.

• 2004

  Acquisition of Priceline, Priceline Pharmacy, House and Price Attack

  [1]Australian Pharmaceutical Industriesen.wikipedia.org

  The retail acquisition accelerated API’s focus on pharmacy-led health and beauty retailing.

• 2002

  Expansion into New Zealand

  [1]Australian Pharmaceutical Industriesen.wikipedia.org

  API acquired Interpacific and Interpharma businesses involved in pharmacy, consumer pharmaceuticals and dental distribution.

• 2001

  Acquisition of Hospital Supplies of Australia

  [1]Australian Pharmaceutical Industriesen.wikipedia.org

  The acquisition extended API’s distribution reach to public and private hospitals.

• 2000

  Acquisition of Washington H. Soul Pattinson operations

  [1]Australian Pharmaceutical Industriesen.wikipedia.org

  API acquired Soul Pattinson’s pharmaceutical wholesaling and manufacturing operations.

• 1998

  Launch of the Chemworld Chemist banner

  [1]Australian Pharmaceutical Industriesen.wikipedia.org

  API introduced a new retail pharmacy banner group.

• 1997

  Acquisition of Amed Supplies Australia and ASX listing

  [1]Australian Pharmaceutical Industriesen.wikipedia.org

  Amed broadened medical and surgical supply coverage, and API listed on the Australian Securities Exchange on 16 June.

• 1996

  Acquisition of Newmans & Western Pharmaceuticals

  [1]Australian Pharmaceutical Industriesen.wikipedia.org

  The acquisition expanded API’s pharmaceutical wholesale operations.

• 1971

  Adopts the Australian Pharmaceutical Industries name

  [1]Australian Pharmaceutical Industriesen.wikipedia.org

  After operating as Wholesale Drug Co, the company adopted its current name.

• 1910

  Incorporated as Chemists’ Co-operative of New South Wales

  [1]Australian Pharmaceutical Industriesen.wikipedia.org

  The business was established as a cooperative serving pharmacy and pharmaceutical wholesale needs in New South Wales.

An integrated Australian pharmacy and health-and-beauty operator combining pharmaceutical wholesaling, pharmacy retail and franchise support with consumer health, skin-care and aesthetic services.

• Pharmaceutical distribution

  Pharmaceutical wholesale distribution

  API’s core business is the wholesale distribution of prescription medicines, over-the-counter products and allied healthcare goods. Its distribution activities support community pharmacies and extend to institutional customers, including public and private hospitals. The business has been enlarged through acquisitions in pharmaceutical, medical, surgical and hospital supply categories.

• Pharmacy retail

  Pharmacy retail and franchise operations

  API operates and supports pharmacy retail through company-owned stores and franchise arrangements. Its retail history includes Priceline Pharmacy, Soul Pattinson and Pharmacist Advice, with the Priceline Pharmacy model becoming a central part of the company’s retail-led strategy in the 2000s.

• Health and beauty retail

  Consumer health and beauty products

  The company distributes and retails health, beauty and personal-care products alongside medicines. This category reflects API’s expansion beyond traditional pharmaceutical wholesaling and its connection with pharmacy-based consumer retail.

• Skin-care clinics · 2018

  Clearskincare Clinics

  Clearskincare Clinics became part of API through a transaction agreed in 2018. API initially acquired a 50.1 percent interest and increased its ownership to full control by September 2021, adding clinic-based skin-care services to its health and beauty portfolio.

• Aesthetic treatment clinics · 2023

  Silk Laser Clinics

  Silk Laser Clinics was acquired by API in November 2023. The business expanded API’s presence in laser and aesthetic treatment services and complemented its existing health, beauty and skin-care activities.

• 2006

  Unaccounted profit after IT-system implementation

  After a new IT system was implemented, API identified A$17.2 million of declared profit that could not be traced. Forensic accountants did not locate the amount, and the company wrote it off, producing a net loss of A$17.2 million. The episode also contributed to the departure of chief executive Jeff Sher after a disagreement with the board about the treatment of the discrepancy.

  Source

• 2005

  Priceline employment dispute under WorkChoices

  Priceline dismissed 32 workers for stated operational reasons during the period of the WorkChoices industrial-relations legislation. A dismissed store-layout planner challenged his termination and alleged that his position had been replaced with a lower-paid role. The Australian Industrial Relations Commission found in Priceline’s favour, concluding that the dismissal resulted from financial difficulties and structural reorganisation.

  Source

Read more

• 2023

  Acquire Silk Laser ClinicsM&A

  Background

  API continued expanding its health and beauty activities after becoming part of Wesfarmers.

  Action taken

  API acquired the Silk Laser Clinics business.

  Aftermath

  The acquisition added laser and aesthetic treatment services to API’s existing pharmacy, skin-care and beauty portfolio.

  Source

• 2022

  Accept Wesfarmers acquisitionM&A

  Background

  API had operated as an ASX-listed Australian pharmaceutical and health-and-beauty company.

  Action taken

  Wesfarmers acquired API for A$774 million.

  Aftermath

  API became part of Wesfarmers and ceased to operate as an independent listed company.

  Acquisition value. A$774 million (March 2022)

  Source

• 2018

  Acquire Clearskincare ClinicsM&A

  Background

  API was broadening its health and beauty activities beyond pharmaceutical distribution and pharmacy retail.

  Action taken

  API agreed to acquire Clearskincare Clinics, initially taking a 50.1 percent stake and later increasing its ownership to 100 percent.

  Aftermath

  Full ownership was reached by the end of September 2021, making the clinic business part of API’s health and beauty portfolio.

  Acquisition consideration. A$127.4 million (2018 acquisition agreement)

  Source

• 2004

  Build a retail-led pharmacy strategy through the Priceline acquisitionStrategy

  Background

  API sought to develop a stronger retail presence alongside its established pharmaceutical distribution business.

  Action taken

  API acquired Priceline, Priceline Pharmacy, House and Price Attack from New Price Retail.

  Aftermath

  The company later sold House and Price Attack and concentrated its retail strategy primarily on Priceline and Priceline Pharmacy.

  Source

• 2002

  Resists Sigma Pharmaceuticals takeover attemptM&A

  Background

  Sigma Pharmaceuticals attempted to acquire API, but the proposal was blocked by the Australian Competition and Consumer Commission.

  Action taken

  The transaction did not proceed because of competition concerns.

  Aftermath

  Sigma later made another approach in 2006, which it withdrew in December of that year.

  • Sigma Pharmaceuticals — Sigma subsequently pursued a second takeover attempt before withdrawing it on 11 December 2006.

  Source

1. 1Australian Pharmaceutical Industriesen.wikipedia.org
2. 2Australian Pharmaceutical Industries official websiteapi.net.au